BioMarin – therapies for rare genetic diseases

BioMarin is a biotech company focusing on the delivery of first-to-market therapies for patients with rare genetic diseases.

BioMarin – therapies for rare genetic diseases

Biomarin Continue reading

Oxyrane – enzyme replacement therapies

Oxyrane develops Enzyme Replacement Therapies (ERTs) for the treatment of lysosomal storage diseases (LSDs) using a proprietary engineered yeast expression platform based on Yarrowia lipolytica.

Oxyrane – enzyme replacement therapies

Oxyrane Continue reading